EUVIMEDDescubrir EUVIMED
Systematische ÜbersichtMetaanalyseOpen access · CC BY 4.0

Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis

Venöse Thromboembolie-Risiko bei Erwachsenen mit hereditärer Thrombophilie: systematische Übersichtsarbeit und Metaanalyse

Anne B Alnor, Charlotte Gils, Pernille J Vinholt

Annals of Hematology · 2024-10 · 103 (10) · 4285-4294

DOI: 10.1007/s00277-024-05926-2 ↗

Auf einen Blick

Die Metaanalyse von 107 Publikationen zeigt ein erhöhtes VTE-Risiko bei erwachsenen Personen mit hereditärer Thrombophilie. Am höchsten war es bei homozygoter FVL-, homozygoter FII-Mutation und Compound-Heterozygotie.

Fragestellung

Wie hoch ist das VTE-Risiko bei Erwachsenen mit hereditärer Thrombophilie?

Methode

Systematische Übersichtsarbeit und Metaanalyse mit Random-Effects-Modell; 107 Publikationen mit extrahierbaren Daten zu VTE-Risiko bei Erwachsenen > 15 Jahre.

Ergebnisse

107 Publikationen mit 107.130 Personen, davon 21.560 mit VTE. Höchstes Risiko: homozygote FVL OR 5,58 (95 %-KI 4,61–6,74), homozygote FII OR 5,16 (95 %-KI 3,12–8,52), Compound-Heterozygotie OR 4,64 (95 %-KI 2,25–9,58).

Schlussfolgerung der Autor:innen

Die Autor:innen berichten ein erhöhtes Risiko für venöse Thromboembolie bei Erwachsenen mit hereditärer Thrombophilie. Für PC-, PS- und AT-Mangel erscheint das Risiko niedriger als zuvor angegeben.

Kernaussagen

  • Höchstes VTE-Risiko bei homozygoter FVL und homozygoter FII
  • FVL-Heterozygotie und FII-Heterozygotie mit niedrigerem Risiko
  • PC-, PS- und AT-Mangel mit intermediärem VTE-Risiko

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Systematische Übersicht in Annals of Hematology, published online on 2024-08-21. Written by Anne B Alnor and 2 co-authors. Institution: Deptartment of Clinical Biochemistry, Odense University Hospital, Odense, Denmark. anne.alnor@rsyd.dk. Major MEDLINE topics: Thrombophilia, Venous Thromboembolism. Cited 20 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY 4.0). Funded by: University of Southern Denmark.

Auf einen BlickResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

This systematic review and meta-analysis assesses venous thromboembolism (VTE) risk in adults with hereditary thrombophilia, including Factor V Leiden (FVL) mutation, prothrombin G20210A (FII) mutation, compound heterozygosity, protein C (PC), protein S (PS), and antithrombin (AT) deficiency. Eligibility criteria included studies suitable for quantitative synthesis with extractable information on VTE risk in adults (> 15 years). There were no restrictions on VTE type, location, or occurrence. Two authors reviewed all studies and extracted data from 107 publications, encompassing 107,130 individuals (21,560 experiencing VTE). We used a random effects model and calculated odds ratios (ORs) with 95% confidence intervals (CIs). The highest risk was associated with homozygous FVL (OR 5.58, 95% CI 4.61–6.74), homozygous FII (OR 5.16, 95% CI 3.12–8.52), and compound heterozygosity (OR 4.64, 95% CI 2.25–9.58). In contrast, VTE risk was lowest for FVL heterozygosity (OR 2.97, 95% CI 2.41–3.67) and FII heterozygosity (OR 2.21, 95% CI 1.70–2.87), whereas PC (OR 3.23, 95% CI 2.05–5.08), PS (OR 3.01, 95% CI 2.26–4.02), and AT deficiency (OR 4.01, 95% CI 2.50–6.44) demonstrated an intermediate VTE risk. These results highlight an increased risk of venous thromboembolism in adults with hereditary thrombophilia. However, the risk for patients with PC, PS, and AT deficiency appears to be lower than previously stated, likely due to varying thrombogeneity of the underlying genetic mutations. Further research addressing this aspect of VTE risk in hereditary thrombophilia is imperative to improve patient management. Trial registration PROSPERO registration number CRD42022376757.

Subjects

MeSH terms (MEDLINE)

ThrombophiliaVenous ThromboembolismHumansAdultRisk FactorsFactor VProthrombinFemaleMale

Author keywords

AntithrombinsProtein CProtein SThrombophiliaVenous thrombosis

Substances

Factor Vfactor V LeidenProthrombin

Authors and institutions

  • Deptartment of Clinical Biochemistry, Odense University Hospital, Odense, Denmark. anne.alnor@rsyd.dk.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark. anne.alnor@rsyd.dk.
  • Deptartment of Clinical Biochemistry, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Funding

  • University of Southern Denmark

Cite

APA

Alnor, A. B., Gils, C., & Vinholt, P. J. (2024). Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis. Annals of Hematology, 103(10), 4285-4294. https://doi.org/10.1007/s00277-024-05926-2

Vancouver

Alnor AB, Gils C, Vinholt PJ. Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis. Annals of Hematology. 2024;103(10):4285-4294. doi:10.1007/s00277-024-05926-2

BibTeX
@article{Alnor2024,
  author = {Alnor, Anne B and Gils, Charlotte and Vinholt, Pernille J},
  title = {Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis},
  journal = {Annals of Hematology},
  year = {2024},
  volume = {103},
  number = {10},
  pages = {4285--4294},
  doi = {10.1007/s00277-024-05926-2}
}
Start for free →